Preventing bipolar relapse: Which factors are associated with different mood stabilizer therapy?

被引：0
|
作者：
Wilhelm, S.
Schacht, A.
Minarzyk, A.
Liebeskind, A.
Grunze, H.
机构：
[1] Lilly Deustchland GmbH, Dept Med, Bad Homburg, Germany
[2] Univ Munich, Dept Psychiat, Munich, Germany
来源：
EUROPEAN PSYCHIATRY | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [11] Interpersonal and social rhythm therapy: A means of improving depression and preventing relapse in bipolar disorder
    Frank, Ellen
    JOURNAL OF CLINICAL PSYCHOLOGY, 2007, 63 (05) : 463 - 473
  • [12] Obsessions and compulsions are associated with different cognitive and mood factors
    Bhar, SS
    Kyrios, M
    BEHAVIOUR CHANGE, 2005, 22 (02) : 81 - 96
  • [13] Risk factors as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study
    Tohen, M.
    Wang, W. V.
    Jen, K. Y.
    BIPOLAR DISORDERS, 2010, 12 : 53 - 54
  • [14] Risk factors as mediators or moderators in predicting relapse to any type of mood episode in a bipolar maintenance study
    Tohen, M.
    Wang, W.
    Jen, K. Y.
    Raskin, J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 132 - 132
  • [15] Clinical and sociodemographic characteristics associated with relapse following electroconvulsive therapy for bipolar disorder
    Thomsen, Rasmus Bengt
    Salagre, Estela
    Rohde, Christopher
    Ostergaard, Soren Dinesen
    BIPOLAR DISORDERS, 2024, 26 (08) : 785 - 792
  • [16] Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: A randomized, placebo-controlled trial
    Chengappa, KNR
    Schwarzmann, LK
    Hulihan, JF
    Xiang, J
    Rosenthal, NR
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S235 - S235
  • [17] Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: A randomized, placebo-controlled trial
    Chengappa, K. N. Roy
    Schwarzman, Lesley K.
    Hulihan, Joseph F.
    Xiang, Jim
    Rosenthal, Norman R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (11) : 1698 - 1706
  • [18] Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder
    Yasui-Furukori, Norio
    Adachi, Naoto
    Kubota, Yukihisa
    Azekawa, Takaharu
    Goto, Eiichiro
    Edagawa, Koji
    Katsumoto, Eiichi
    Hongo, Seiji
    Ueda, Hitoshi
    Miki, Kazuhira
    Kato, Masaki
    Yoshimura, Reiji
    Nakagawa, Atsuo
    Kikuchi, Toshiaki
    Tsuboi, Takashi
    Watanabe, Koichiro
    Shimoda, Kazutaka
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2020, 18 (04) : 599 - 606
  • [19] Factors associated with dropout in a group cognitive behaviour therapy for mood disorders
    Oei, TPS
    Kazmierczak, T
    BEHAVIOUR RESEARCH AND THERAPY, 1997, 35 (11) : 1025 - 1030
  • [20] Lamotrigine add-on therapy to mood stabilizer in bipolar patients with subsyndromal symptoms: A 12-week, prospective, naturalistic, observational study
    Bahk, Won-Myong
    Woo, Young Sup
    Pae, Chi-Un
    Jeong, Jong-Hyun
    Kim, Moon-Doo
    Koo, Bon-Hoon
    Jon, Duk-In
    ASIA-PACIFIC PSYCHIATRY, 2012, 4 : 184 - 184
12345